Posid 50mg

Posid 50 mg for injection is an antineoplastic agent available for intravenous infusion as a sterile lyophile in single-dose vials containing etoposide as the active ingredient. It is combined with other chemotherapeutic drugs to treat patients with testicular tumours and small-cell lung cancer. Refractory Testicular tumours: Posid for injection in combination therapy with other approved chemotherapeutic agents in patients with refractory testicular tumours who already received appropriate chemotherapeutic, radiotherapeutic, and surgical therapy. Small cell lung cancer: Posid capsule for injection is used with other approved chemotherapeutic agents as first-line treatment in patients with small cell lung cancer.